RP

Rohan Prakashrao Wallamwad

Active Director Director DIN 08734021
DIN 08734021 First appointment Apr 2020 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Rohan Prakashrao Wallamwad

Data last updated:

Rohan Prakashrao Wallamwad is a Director at Medithos Healthcare Private Limited (since 2020). The company operates in Pharma.

DIN 08734021
Primary Designation Director
Industry Pharma
First Appointment 13 Apr 2020
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medithos Healthcare Private Limited U85100MH2020PTC339346
Director13 Apr 20202020Active

Board colleagues of Rohan Prakashrao Wallamwad

Directorship timeline

Open interactive timeline →
Medithos Healthcare Private Limited
Premium access

Shareholding and investment profile for Rohan Prakashrao Wallamwad

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rohan Prakashrao Wallamwad

Rohan Prakashrao Wallamwad currently holds 1 directorship: Medithos Healthcare Private Limited (Director, since 13 Apr 2020).

Rohan Prakashrao Wallamwad was first appointed on 13 Apr 2020 as Director at Medithos Healthcare Private Limited.

The current boards of Rohan Prakashrao Wallamwad's companies include Pradip Vyankati Chilavant (Medithos Healthcare Private Limited), Santosh Limbraj Waybase (Medithos Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available